Definium Therapeutics Inc. Common Shares vs Flowserve Corporation Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Flowserve Corporation Common Stock trades at $70.6 (market cap $8.96B). The key difference: Flowserve Corporation Common Stock is the larger of the two by market cap, and Flowserve Corporation Common Stock pays a 1.25% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Flowserve Corporation Common Stock for 0 Days on average.
| DFTX | FLS | |
|---|---|---|
Market Cap | $4.71B | $8.96B |
Volume | 1,966,636 | 1,946,178 |
Sector | Health | Industrials |
52-Week High | $48.45 | $92.04 |
52-Week Low | $10.68 | $49.09 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $10.55B |
Dividend Yield | — | 1.25% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Flowserve Corporation is a Texas-based manufacturer of engineered flow-control equipment, producing industrial pumps, mechanical seals, valves, and automation products through its Flowserve Pumps Division and Flow Control Division, serving the oil and gas, chemical, power, and water industries in more than 50 countries.
Read more on FLS →